Skip to main content
. 2020 Dec 15;5(4):305–317. doi: 10.1089/can.2019.0099

FIG. 5.

FIG. 5.

Effects of TRPV1 agonists and terpenoids on hTRPV1 cells. (A, B) Concentration–response curves of hTRPV1 agonists CAPS and AEA. (C) Representative trace showing the application of 10 μM β-pinene (blue) and 10 μM CAPS on hTRPV1 (black). (D) Maximum change in fluorescence upon application of vehicle, 10 μM terpenoid or 10 μM CAPS. N>5, mean±SEM, unpaired t-test. Drugs were added for the duration of the bar. AEA, anandamide; CAPS, capsaicin; hTRPV1, human transient receptor potential vanilloid 1.